Oxidized MIF is an Alzheimer’s drug target

Written By John Flores

Oxidized MIF is an Alzheimer’s Disease drug target relaying external risk factors to tau pathology. Click here for the full article.

John Flores https://boxc.ar
Previous

Prosetta in drug discovery news
Next

Prosetta in the Scripps Research Institutes NIH-funded Center for Pandemic Preparedness